Lifestyle interventions (including diet, exercise and behavioural changes) are the cornerstone of obesity management with diverse benefits, but even the most intensive lifestyle interventions result in up to 10% mean weight loss (WL) and weight maintenance remains a challenge, as 80% of WL is expected to be regained over the next 5 years [4, 5]
And it was related to the severity of CAS
If you are looking for a bit cleaner of a UI and dont want the estimated medication levels, try Shotsy.
We dont know what we dont know, warns Dr
This common concern affects many patients starting glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), or dulaglutide (Trulicity) for type 2 diabetes or weight management
Clinical Evidence Comparison Prescription GLP-1 medications have been studied in large-scale clinical trials with thousands of participants, demonstrating significant and reproducible effects sufficient for FDA approval